Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
Momenta’s failed pancreatic cancer drug is given a midnight funeral
Endpoints
Fri, 09/2/16 - 09:39 am
Momenta Pharmaceuticals
pancreatic cancer
necuparanib
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
Fri, 07/8/16 - 11:01 am
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
Clovis Oncology Presents Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer and Pancreatic Cancer at 2016 ASCO Annual Meeting
Yahoo
Mon, 06/6/16 - 11:04 am
Clovis Oncology
rucaparib
ovarian cancer
pancreatic cancer
ASCO 2016
Aduro Biotech Pancreatic Cancer Immunotherapy Fails Mid-Stage Study
TheStreet.com
Mon, 05/16/16 - 11:09 am
Aduro BioTech
pancreatic cancer
clinical trials
CRS-207
NewLink Genetics writes off pancreatic cancer immunotherapy after phase 3 failure
BioPharma Dive
Tue, 05/10/16 - 10:33 am
NewLink Genetics
pancreatic cancer
algenpantucel-L
Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Bizjournals.com
Tue, 05/3/16 - 10:09 am
Merrimack Pharmaceuticals
Onivyde
pancreatic cancer
Oxigene's pancreatic cancer treatments granted orphan drug status in Europe
Marketwatch
Sat, 03/26/16 - 01:01 pm
Oxigene
pancreatic cancer
orphan drugs
CA4P
Gilead Ends a Phase 2 Study for Antibody
WSJ Online
Wed, 01/6/16 - 08:00 pm
Gilead Sciences
simtuzumab
pancreatic cancer
NewLink Genetics Vaccine May Improve How We Treat Pancreatic Cancer
Motley Fool
Wed, 12/23/15 - 09:52 pm
vaccines
pancreatic cancer
NewLink Genetics
algenpantucel-L
clinical trials
Bristol-Myers Squibb's Opdivo May Change How We Treat Pancreatic Cancer
Motley Fool
Sun, 11/29/15 - 12:36 pm
Bristol-Myers Squibb
Opdivo
pancreatic cancer
FDA clears Merrimack's pancreatic cancer drug with warning
Yahoo/Reuters
Thu, 10/22/15 - 07:28 pm
FDA
Merrimack Pharmaceuticals
pancreatic cancer
warnings
Onivyde
OncoGenex's drug misses the mark in pancreatic cancer
Fierce Biotech
Wed, 09/23/15 - 09:58 am
OncoGenex
pancreatic cancer
apatorsen
Celgene
Abraxane
NewLink Genetics shares fall after saying it will continue pancreatic cancer treatment study
Yahoo/AP
Wed, 05/13/15 - 09:50 am
NewLink Genetics
pancreatic cancer
algenpantucel-L
Merck KGaA, Threshold win fast track for pancreatic cancer drug
Yahoo/Reuters
Tue, 05/12/15 - 10:19 am
Merck KGaA
Threshold Pharmaceuticals
pancreatic cancer
FDA
fast track
evofosfamide
Halozyme Provides Update Following Type B FDA Meeting
Yahoo
Wed, 04/8/15 - 10:44 am
Halozyme
FDA
PEGPH20
pancreatic cancer
Merrimack pancreatic cancer product candidate fast tracked
Seeking Alpha
Thu, 11/20/14 - 09:04 am
pancreatic cancer
Merrimack Pharmaceuticals
FDA
fast track
OncoMed's Demcizumab Phase 1b Clinical Trials Show Encouraging Safety and Anti-Tumor Activity at ESMO
Yahoo/Globe NewsWire
Sun, 09/28/14 - 09:41 am
OncoMed
demcizumab
non-small cell lung cancer
pancreatic cancer
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Wed, 09/24/14 - 08:30 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Yahoo/Zacks
Sat, 09/20/14 - 08:52 am
Halozyme
PEGPH20
pancreatic cancer
metastatic pancreatic cancer
Gilead Sciences: Failed Trial Always a ‘Long Shot’
Barron's
Thu, 09/18/14 - 12:03 pm
Gilead Sciences
clinical trials
pancreatic cancer
simtuzumab
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »